2023
DOI: 10.1016/j.carpta.2023.100316
|View full text |Cite
|
Sign up to set email alerts
|

Unraveling the role of chitosan for nasal drug delivery systems: A review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(3 citation statements)
references
References 112 publications
0
3
0
Order By: Relevance
“…Additionally, other crosslinking agents like glutaraldehyde, formaldehyde, and the naturally occurring genipin have been employed for microsphere preparation. Various methods, including coacervation, multiple emulsion, and solvent evaporation, have been utilized for the preparation of chitosan microspheres, allowing for the modification of particle sizes suitable for oral, nasal, and parenteral drug delivery [153,154].…”
Section: Permeation Enhancermentioning
confidence: 99%
“…Additionally, other crosslinking agents like glutaraldehyde, formaldehyde, and the naturally occurring genipin have been employed for microsphere preparation. Various methods, including coacervation, multiple emulsion, and solvent evaporation, have been utilized for the preparation of chitosan microspheres, allowing for the modification of particle sizes suitable for oral, nasal, and parenteral drug delivery [153,154].…”
Section: Permeation Enhancermentioning
confidence: 99%
“…According to Kaur et al (2023), nanoscience and technology were used more and more in targeted drug administration to increase therapeutic efficacy and safety over the previous 20 years. Biodegradable polymers, such as those found in CS drug delivery systems, provide an alternative to controlled drug release through the nose.…”
Section: The Potential Challenges Of Utilizing Chitosan and Its Nanof...mentioning
confidence: 99%
“…A challenging topic studied lately has been the intranasal administration of drugs, due to its advantages. Many drug administration systems are based on chitosan or its derivatives, such as gels for the intranasal administration of antihistamines (loratadine and chlorpheniramine) [10]; insulin [11]; liposomes and nanoemulsions for the administration of a derivative of Dehydroepiandrosterone (DHEA) [12]; microemulsion with silymarin for the treatment of Parkinson's disease [13]; nanoparticles with galantamine [14] or ropinirole [15]; and nanocrystals with memantine for the treatment of Alzheimer's disease [16].…”
mentioning
confidence: 99%